It will start to build. This was another de-risking and the rerate will come at any time.
As a reminder, here are the announcements we are expecting in the coming weeks:
1. Patent granted in the USA
2. First patient in DARRT-2
3. First patient in IONIC
4. NOXCOVID-2 trial details
5. Hudson TBK1 paper
6. Pharmorage strategy (spinoff/IPO?)
7. LUPIN-2 trial details
8. Full NOXCOVID-1 data
All this and more, expected imminently!
Radiotherapy Improvements ALLOWED, page-22
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
